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ABSTRACT
Background
Coronary angiography (CA) is the gold standard in diagnosing and determining the treatment of patients 
with coronary heart disease. Procedure-related neurological complications are rare; 0.1-0.4% for CA and 
percutaneous coronary intervention (PCI).  In contrast, the incidence of procedure-related silent cerebral 
lesions, shown with diffusion-weighted magnetic resonance tomography, is considerably higher (2-35%). 
Cerebral microemboli have been observed during different vascular procedures and are related to new silent 
cerebral lesions but their clinical impact is debated. CA and PCI can be performed with different techniques, 
i.e. with the radial or the femoral access. As procedure-related stroke is associated with high mortality, 
considerable morbidity and suffering it is important to study which technique entails the lowest risk for 
patient injury.
Methods and results
Study I: Fifty-one patients with stable angina pectoris were randomised to CA with the radial or the femoral 
access and the number of cerebral microemboli was assessed with bilateral transcranial Doppler technique 
of the middle cerebral arteries (MCAs). The number of particulate cerebral microemboli was significantly 
higher with the radial compared to the femoral access. The number of cerebral microemboli was higher for 
both access sites during catheter exchanges compared with other specific procedural steps during CA, with 
most cerebral microemboli detected in the right MCA in the radial group. This indicates a causal anatomical 
link, as the catheter is advanced from the right radial artery through the brachiocephalic trunk before it bends 
into the ascending aorta to reach the coronary ostia.
Study II: Forty-one patients with stable angina pectoris or non-ST-segment-elevation myocardial infarction 
scheduled for CA were randomised to two different guidewire techniques with the femoral access involving 
catheter advancement with or without a leading guidewire over the aortic arch. After the CA was completed, 
including contrast injections, the opposite technique was used on the same patient without further contrast 
injections.  At the same time, the number of cerebral microemboli was registered using bilateral transcranial 
Doppler technique. The number of cerebral microemboli was higher when the catheter was advanced with, 
rather than without a leading guidewire over the aortic arch, independent of whether a complete CA was 
performed or if a catheter was placed in the vicinity of the coronary ostia only.
Study III: All CAs and PCIs reported between 2003 and 2011, n= 336,836, to the Swedish Coronary 
Angiography and Angioplasty Register with information on access site were retrospectively analysed 
regarding the association between access site and procedure-related stroke or transient ischemic attack 
(TIA). After cross-checking the reported neurological complications with the corresponding medical records 
the incidence of procedure-related stroke or TIA was 0.16%. After multivariable adjustment, the radial 
access was associated with a higher risk for procedure-related stroke or TIA (risk ratio 1.30, 95% confidence 
interval 1.04-1.62) compared with the femoral access. Parallel to the increased use of the radial access over 
time, the risk for procedure-related stroke or TIA also increased, although there was no significant interaction 
between the different time intervals observed.
Study IV:  Ninety-three patients with suspected or stable angina pectoris scheduled for CA or PCI were tested 
with Montreal Cognitive Assessment (MoCA) before and twice after the coronary procedure to study post-
procedural cognitive impairment. A subgroup was monitored with bilateral transcranial Doppler technique 
to explore the relationship between cerebral microemboli and cognitive function. The patients were also 
randomised to radial or femoral vascular access site to study if the access site used was related to post-
procedural cognitive impairment. Cognitive function assessed with the MoCA test was not impaired after the 
coronary procedure. There was no significant correlation between the results of the MoCA test and cerebral 
microemboli or vascular access site.
Conclusions
The choice of access site and guidewire technique used for CA and PCI had an impact on the occurrence 
of cerebral microemboli. There may be an association between the radial access and increased risk for 
procedure-related stroke or TIA, which should be studied further. Earlier studies have shown that cerebral 
microemboli are related to new silent cerebral lesions, but we found no cognitive impairment after coronary 
procedures using the MoCA test. Further studies are needed to explore the clinical impact of cerebral 
microemboli and to minimise or prevent the occurrence of procedure-related ischemic cerebral lesions in 
patients undergoing CA and PCI.
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SAMMANFATTNING
Bakgrund
Kranskärlsröntgen är standardundersökningen för diagnostik och beslut om behandling av patienter 
med ischemisk hjärtsjukdom. Procedurrelaterade neurologiska komplikationer är sällsynta; 0,1-0,4% 
vid kranskärlsröntgen och kranskärlsinterventioner. Däremot är uppkomsten av procedurrelaterade 
tysta hjärninfarkter, diagnosticerade med diffusionsviktad magnetisk resonanstomografi betydligt 
vanligare (2–35%). Cerebrala mikroembolier har observerats under olika kärlingrepp och associerats 
med nytillkomna tysta hjärninfarkter, men deras kliniska betydelse är omstridda. Kranskärlsröntgen och 
kranskärlsinterventioner kan tekniskt utföras på olika sätt, exempelvis via radialis- eller femoralisartären. 
Eftersom procedurrelaterad stroke är kopplad till hög dödlighet, betydande sjuklighet och lidande är det 
viktigt att undersöka vilken teknik som medför lägst risk för patientskada.
Metoder och resultat
Studie I: 51 patienter med stabil kranskärlssjukdom randomiserades till kranskärlsröntgen via radialis- eller 
femoralisartären och antalet cerebrala mikroembolier monitorerades via transkraniell Doppler i bägge 
cerebrimediaartärerna. Signifikant fler solida cerebrala mikroembolier registrerades i radialisgruppen 
jämfört med femoralisgruppen. Antalet cerebrala mikroembolier var högre för båda kärlaccesserna vid 
kateterbyte jämfört med andra specifika moment under kranskärlsröntgen med flest cerebrala mikrombolier 
detekterade i högra cerebrimediaartären i radialisgruppen. Detta talar för ett kausalt anatomiskt samband, 
eftersom katetern framförs vid instick i högra radialisartären via truncus brachiocephalicus innan den böjs i 
aorta ascendens för att nå koronamynningarna.
Studie II: 41 patienter med stabil kranskärlssjukdom eller icke ST-höjningsinfarkt planerade för 
kranskärlsröntgen randomiserades till två olika kateteriseringstekniker via femoralisartären, som 
innebär kateterisering med eller utan ledare över aortabågen. Efter avslutad kranskärlsröntgen, med 
kontrastinjektioner, genomfördes den andra kateteriseringstekniken på samma patient, men utan ytterligare 
kontrastinjektioner. Samtidigt registrerades cerebrala mikroembolier med transkraniell Doppler bilateralt. 
Antalet cerebrala mikroembolier var högre när katetern fördes med ledaren över aortabågen jämfört med 
utan ledare, oavsett om en fullständig kranskärlsröntgen utfördes eller om katetrar enbart placerades vid 
kranskärlsmynningarna.
Studie III: Alla kranskärlsröntgen och kranskärlsinterventioner som rapporterats till det Svenska 
koronarangiografi- och angioplastikregistret med uppgift om instickställe mellan 2003 och 2011, n= 336836, 
analyserades retrospektivt med avseende på sambandet mellan kärlaccess och procedurrelaterad stroke eller 
transitorisk ischemisk attack (TIA). Efter att de rapporterade neurologiska komplikationerna hade verifierats 
med inhämtade journaler från respektive patient, beräknades incidensen av procedurrelaterad stroke eller 
TIA till 0,16%. Efter justering för flera förväxlingsfaktorer var kranskärlsröntgen eller kranskärlsintervention 
via radialisartären associerad med ökad risk för procedurrelaterad stroke och TIA, (risk ratio 1,30, 95% 
konfidensinterval 1,04-1,62) jämfört med motsvarande undersökning via femoralisartären. Under 
observationstiden ökade risken för procedurrelaterad stroke eller TIA  parallelt med ökande antal 
kranskärlsröntgen och kranskärlsinterventioner via radialisartären, utan signifikant interaktion mellan 
observationstidens olika tidsintervaller.
Studie IV: 93 patienter med misstänkt eller stabil kranskärlssjukdom planerade för kranskärlsröntgen eller 
kranskärlsintervention testades med Montreal Cognitive Assessment (MoCA) före och två gånger efter 
kranskärlsproceduren för att undersöka om deras minnesfunktion hade försämrats efter ingreppet. I en 
undergrupp användes transkraniell Doppler bilateralt för att utreda ett eventuellt samband mellan cerebrala 
mikroembolier och minnesfunktion. Slutligen randomiserades patienterna till instickställe för att undersöka 
om kärlaccess hade en inverkan på minnesfunktion efter proceduren. Minnesfunktionen försämrades 
inte efter kranskärlsröntgen när den testades med MoCA. Det fanns ingen signifikant korrelation mellan 
resultaten från MoCA testen och och antalet cerebrala mikroembolier eller instickställe. 
Slutsats
Val av kärlaccess och ledarteknik vid kranskärlsröntgen och kranskärlsintervention påverkade antalet 
cerebrala mikroembolier. Det kan finnas ett samband mellan radialisaccess och ökad risk för procedurrelaterad 
stroke eller TIA, vilket bör studeras vidare. Tidigare studier har visat att cerebrala mikroembolier är 
kopplade till nytillkomna tysta hjärninfarkter, men vi kunde inte påvisa försämrad minnesfunktion efter 
kranskärlsproceduren med MoCA test. Ytterligare studier krävs för att bättre kartlägga den kliniska betydelsen 
av cerebrala mikroembolier och för att kunna minska eller förhindra uppkomsten av procedurrelaterade 
ischemiska cerebrala lesioner hos patienter som genomgår kranskärlsröntgen och kranskärlsinterventioner.
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INTRODUCTION
Historical background and technique
The first cardiac catheterisation in man is considered to have been performed by the German 
surgeon Werner Forssman, who in 1929, advanced a catheter for 60 cm into the right atrium 
via his left antecubital vein (1). For this he shared the Nobel Prize 27 years later. Sven I. 
Seldinger, a Swedish radiologist, contributed in 1953 to an atraumatic approach by the 
invention of the percutaneous technique, still the gold standard for entering blood vessels 
for catheterisation (2). Other milestones were the first selective coronary angiography 
(CA) reported by the American cardiologist Mason Sones in 1959 (3) and the first balloon 
angioplasty treatment, known as percutaneous transluminal coronary angioplasty (PTCA) 
by the German cardiologist Andreas R. Grüntzig in 1977 (4). In 1987, for the first time, the 
German cardiologist Ulrich Sigwart and colleagues placed a metallic scaffold, termed stent, 
within a diseased coronary artery segment to maintain luminal patency (5). Stents improved 
early and late results of balloon angioplasty. The results have been further enhanced by the 
release of anti-proliferative bioactive agents (drug eluting stents) (6). Since then, the broader 
term percutaneous coronary intervention (PCI) has been adopted which also includes the use 
of various devices. PCI is the most common revascularization modality practiced in patients 
with coronary artery disease (CAD).
During cardiac catheterisation, the Seldinger technique is applied by puncture of the vessel 
wall with a needle through which a flexible guidewire is advanced, remaining intravascular 
as the needle is withdrawn allowing a sheath to be placed upon it (Figure 1). The sheath is 
equipped with a back-bleed valve and a side port, supporting catheter placement and drug 
administration.
Figure 1. Seldinger technique.
The vessel is entered by a needle through which the guidewire is inserted.
          Cardiac catheterisation and procedure-related cerebral complications
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Femoral Access
Since the American radiologist Melvin P. Judkins further modified selective CA in 1967, the 
femoral access has been the standard access for percutaneous coronary procedures, enabling 
the use of large sized catheters (7). The common femoral artery is punctured 1-2cm distal from 
the inguinal ligament (8) and a sheath is placed with the help of a guidewire. The guidewire is 
introduced through the sheath and advanced to the abdominal aorta followed by the insertion 
of a flushed catheter over the guidewire to be then advanced together with the guidewire to 
the thoracic aorta. Currently two catheterisation techniques exist: when applying the Judkins 
technique, the leading guidewire is withdrawn in the descending aorta (7), whereas catheters 
are advanced over the aortic arch with help of a leading guidewire using the other technique 
(9), (Figure 2). It is claimed that the latter technique is preferable as the risk for dislodging 
arteriosclerotic debris from the aortic arch is minimised (10). Operators’ preference for either 
technique is governed by local traditions and evidence regarding the prevention of ischemic 
neurological complications is rare. To achieve hemostasis after the catheterisation, removal 
of the femoral arterial sheath is followed by either compression of the vascular entry, applied 
manually or by mechanical devices (FemoStop®, St. Jude Medical Inc., ST. Paul, MN, USA) 
or closure by vascular devices (AngioSeal®, St. Jude Medical Inc., ST. Paul, MN, USA ) 
which reduces the time for hemostasis using a resorbing plug at the arterial puncture site (11). 
Figure 2. Catheter and guidewire techniques used with the femoral access. 
Panel A shows the Judkins technique with guidewire withdrawal in the descending aorta followed by advancement 
of the catheter alone over the aortic arch.
Panel B shows the other technique with advancement of the catheter with help of a guidewire over the aortic arch.
A B
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Radial access
In 1989 the Canadian cardiologist Lucien Campeau reported the first transradial CA (12), 
further developed by Ferdinand Kiemeneij, interventional cardiologist from the Netherlands, 
who in 1992 performed the first transradial percutaneous coronary intervention (PCI) (13). 
The patency of the palmar arch should be assessed, as radial artery occlusion is reported to 
occur in 2-30% following transradial catheterisation (14, 15). The radial artery is punctured 
1-2cm proximal of the radial styloid process and a sheath is placed with the help of a guide-
wire. Then 2,000-5,000 international units (IU) of heparin are administrated to avoid throm-
botic radial artery occlusion (16). To prevent radial artery spasm, a “cocktail” of vasodilata-
tors including different compositions of nitroglycerine and verapamil can be administered 
through the sheath (17). In comparison with the femoral access, the diagnostic catheter is 
advanced over a longer guidewire to the ascending aorta. As the right radial access is mainly 
used (18), the catheter has to be advanced from the radial, brachial and subclavian artery to 
the brachiocephalic trunk, where it has to bend sharply into the ascending aorta on its way to 
the coronary orifices. In addition to anatomical variations of the radial artery including loops 
and bifurcations, tortuosities at all other levels proximal from the radial artery can appear, 
requiring caution and readiness to change access (19). The radial sheath is directly removed 
after completion of the catheterisation procedure and a compression device (i.e. TR Band®, 
Terumo Corp., Tokyo, Japan) is placed over the puncture site to achieve hemostasis.
Although technically more demanding, recently the radial access has been increasingly used, 
in over 80% of all catheterisations in Sweden (20), 40% in Europe and 16% in the USA 
(21, 22). This is mainly explained by fewer major access site bleedings compared with the 
femoral access (23, 24) leading to mortality benefits for patients with STE-ACS (25) where 
access site bleeding represents 30-70% of total bleeding events (26).  Despite this, there have 
been concerns about higher rates of procedure-related ischemic cerebral embolic events with 
the radial access (27). 
Radial versus femoral access
Advantages of the radial artery access include the superficial anatomic position enabling easy 
compression, absence of important adjacent structures, faster time to ambulation, high patient 
preference and reduced periprocedural discomfort in a mixed population (28, 29). Compared 
to men, women are recognised as having smaller radial arteries and may be more prone to 
spasm, which has been shown to be a major cause of procedure failure with the radial access 
(30, 31). When quality-of-life and impairment of functional status were examined following 
CA and PCI, women, asked for repeat  procedures, preferred the radial compared with the 
femoral access, although there was no difference in these factors between the access sites 
(32). Limitations of the radial access comprise small artery size restricting the use of some 
interventional devices for complex procedures and higher radiation exposure (19, 33).
Different studies have compared the radial and femoral access for cardiac catheterisations in 
terms of clinical outcome. When Agostoni and co-workers published  the first meta-analysis 
the aim was to combine several small sized randomised controlled trials (RCT) to achieve 
more statistical power (34). They found a similar risk for major adverse cardiac events 
(MACE), but substantially fewer vascular access site complications with the radial access 
compared to the femoral access (34). Five years later, Jolly and co-workers published a meta-
          Cardiac catheterisation and procedure-related cerebral complications
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analysis including twice as many patients and concluded that the radial access was associated 
with a reduction in major bleedings, but without an effect on the combined endpoint death, 
myocardial infarction (MI) and stroke (35). With inclusion of observational studies and RCTs 
in a huge meta-analysis consisting of over 750,000 patients treated with PCI, Bertrand and co-
workers confirmed fewer major bleedings and demonstrated reduced mortality with the radial 
compared with the femoral access. The mortality benefit was mainly due to observational 
studies (23). More recently published studies focused on high-risk groups when comparing 
outcome according to access site. Both Karowni and co-workers (25) and Pancholy and co-
workers (36) associated the radial access with mortality benefits in patients with ST-segment 
elevation myocardial infarction (STEMI), but the latter included only patients in cardiogenic 
shock, from cohort studies. Notwithstanding the value of combining studies to generate a large 
sample size, meta-analyses have several limitations: besides selection bias, heterogeneity 
of the studies included, different primary end-points (in hospital versus 30 day mortality), 
operator or centre experience, type of procedure (some studies include CA), patient cohort 
(proportion of ACS patients), and substantial disparities of bleeding definitions used. 
The RIVAL trial, presented in 2011, the first large-scale RCT comparing outcome of the two 
vascular access sites, showed no difference for the composite endpoint of death, MI, stroke, 
and  non-coronary artery bypass graft (non-CABG) related major bleeding in ACS patients 
undergoing CA with possible intervention, while the subgroup analysis showed benefits 
for STEMI patients with the radial access (37). The RIFLE-STEACS trial, published one 
year later, has demonstrated beneficial outcome for STE-ACS (ST-segment elevation acute 
coronary syndrome) patients treated via the radial compared with the femoral access in the 
composite of cardiac death, stroke, MI, target lesion revascularization and bleeding (38). 
These findings were confirmed by the STEMI-RADIAL trial (39). When the composites 
of the combined endpoint were analysed separately, bleeding rates and cardiac mortality 
were significantly lower in the radial arm of the RIFLE-STEACS trial, whereas the STEMI-
RADIAL trial did not show a significant reduction in mortality despite the similarity in 
patient cohorts and primary endpoints (38, 39). Obviously, the latter negative finding may be 
explained by the smaller sample size in STEMI-RADIAL (39), but due to earlier ambulation 
with the radial access, in-hospital stay was 1 day shorter with the radial than with the femoral 
access in RIFLE-STEACS, which may be a potentially contributory factor to a reduced 
mortality (38). In the recently published MATRIX study, the radial access, in comparison with 
the femoral access, decreased the composite endpoint rate of death, MI, stroke or bleeding in 
ACS patients by a reduction in major bleeding and all-cause mortality (40). 
Although considerably higher compared to register-based incidence (0.3-0.7%), no significant 
difference in stroke incidence was reported in the above mentioned RCTs including an 
updated meta-analysis presented with the MATRIX results (37-40). Given the low incidence 
of procedure-related stroke or transient ischemic attack (TIA), adequately powered RCTs 
are difficult to implement. Thus, these RCTs were not designed to evaluate procedure-
related stroke or TIA rates. Recently published observational studies have addressed this 
question. In a rather small single centre study, Raposo and co-workers did not find significant 
differences in stroke or TIA rates between the access sites when analysing 27 patients with 
confirmed diagnosis of stroke and TIA (41). No association between vascular access site and 
neurological complications was reported by Ratib and co-workers based on data from a PCI 
registry including over 300,000 patients (42). However, register studies could lack accuracy 
regarding the reported neurological complications and are influenced by several confounders. 
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In addition to being large-scale, high-quality register-based studies have the capability to 
shed light on the question of whether vascular access site has an impact on procedure-related 
stroke or TIA , which was the reason for designing Study III.
The above discussed studies are summarised in Table 1.
Indications for CA and PCI
According to European and American guidelines, noninvasive stress testing is appropriate 
for initial diagnosis and risk stratification for most patients with suspected ischemic 
heart disease (43, 44). However, CA is the gold standard in evaluating the diagnosis and 
determining the treatment of patients with ischemic heart disease, with annually 40,000 and 
2 million procedures performed in Sweden (20) and in the United States, respectively (45). 
The intraluminal obstruction of a coronary artery is visualised two-dimensionally with CA, 
but the extension of the atheroma within the vessel wall and the functional significance of 
the stenosis can only be assumed. By combining CA with further invasive intravascular 
modalities such as intravascular ultrasound (46), optical coherence tomography (47) and 
fractional flow reserve (48), appropriate treatment strategies can be determined.
Depending on clinical situations, indications for CA can be separated into three main 
categories: (i) assessment in stable and (ii) unstable CAD and in special conditions (iii). 
Furthermore it should be considered whether CA is performed due to symptomatic or 
prognostic reasons. 
Thus, patients with severe stable angina pectoris, classified as Canadian Cardiovascular Society 
(CCS) grade III, which is equal to marked limitation after one flight of stairs (49),  despite 
optimal medical treatment, have a recommendation for CA followed by revascularization for 
symptom relief in accordance with the European Society of Cardiology (ESC) and American 
College of Cardiology/American Heart Association (ACC/AHA) guidelines (43, 44). Mild 
symptoms are accepted only in patients in whom non-invasive risk stratification indicates a 
high-event risk, aiming for revascularization for improvement of prognosis (44). 
Non-ST-segment elevation acute coronary syndrome (NSTE-ACS) as an entity of unstable 
CAD that should be treated invasively, which is recommended in both the ESC and ACC/
AHA guidelines (50, 51) due to morbidity benefits (reduced risk for recurrent ACS episodes, 
rehospitalisations and revascularization) (52-54). Also a survival benefit after invasive 
treatment in NSTE-ACS has been suggested, but convincing evidence is lacking as different 
meta-analyses have shown divergent results. A Cochrane review found no improved survival 
(52), Fox and co-workers found a risk reduction in high-risk patients (53) whereas Bavry 
and co-workers reported a reduced risk for mortality following invasive compared with 
conservative treatment (54). The optimal timing for early invasive approach is still subject to 
research, although high-risk patients with NSTE-ACS should undergo CA with subsequent 
revascularization within 24 hours (h) from the onset of symptoms (51).  
Timely invasive management with primary PCI of patients with ST-segment elevation 
acute coronary syndrome (STE-ACS) is superior to fibrinolysis to restore blood flow in the 
infarct-related artery, in terms of survival, intra-cranial haemorrhage and recurrent MI (55). 
This approach is therefore recommended by the ESC and ACC/AHA guidelines as first-line 
treatment in areas with PCI facilities available (56, 57). 
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Also, survivors of cardiac arrest should undergo CA (56), as 80% have ACS as a precipitating 
factor (58, 59). Special conditions for elective CA comprise heart failure, heart transplant, 
structural heart disease or valve disease and preoperative risk assessment for non-cardiac 
surgery. Table 2 summarises the indications for CA by showing the proportions of CAs 
performed in Sweden in 2014.
Complications of CA and PCI
The spectrum of procedure-related complications varies from minor without leaving sequelae 
to major complications including death. Periprocedural complications are influenced by 
multiple components such as patient-related factors (age, burden of other diseases), cardiac 
anatomy (severe CAD/left main disease, structural heart disease), the clinical situation, 
Table 2.  Indication for coronary angiography with  number and proportion of patients in 
the Swedish Angiography and Angioplasty Registry (SCAAR) performed 2014 (20).
Indication Number Proportion 
(%)
NSTEMI 8 491 21.2
Stable angina pectoris 8 265 20.7
Unstable angina pectoris 6 678 16.7
STEMI 5 418 13.6
Unspecified chest pain 3 136 7.8
Investigation for congenital heart defects and
valve pathologies 2 931 7.3
Investigation for congestive heart failure/cardiomyopathy 1 700 4.3
Arrhythmia investigation 945 2.4
Other 395 1.0
Cardiac arrest no STEMI 380 1.0
Silent ischaemia 335 0.8
STEMI >24h 308 0.8
Cardiac arrest with STEMI 220 0.6
Pre- or post transplant investigation 219 0.5
Aortic aneurysm/dissection 158 0.4
STEMI/Rescue PCI 136 0.3
Risk assessment after successful thrombolysis 85 0.2
Suspected complication after angiography/PCI 75 0.2
Suspected complication after CABG 54 0.1
Research and development 16 0.0
Angiography not possible to perform 11 0.0
Mechanical complication after MI 9 0.0
Total 39 965 100.0
CABG= coronary artery bypass graft, NSTEMI= non-ST-segment elevation myocardial infarction, MI= myocar-
dial infarction, PCI= percutaneous coronary intervention, STEMI= ST-segment elevation myocardial infarction
          Cardiac catheterisation and procedure-related cerebral complications
17
type of procedure performed and also operator experience. The procedure-related mortality 
risk is 0.1% for cardiac catheterisation (60-62) and 1.4-2.2% for PCI procedures (63-65). 
Other major periprocedural complications include MI 0.1% for CA (62, 66) and 0.4-20% for 
PCI (63, 67), depending on the definition used for MI (Q-wave versus creatine kinase-MB 
fraction elevation in blood sample). Vascular complications are reported to occur equally often 
(0.5%) for CA and PCI (62, 68, 69). Bleeding is the most common complication, reported 
as major bleeding in registries at a rate between 1.7-5.4% (20, 69-72) and is associated with 
a significant morbidity and mortality (70). Different strategies to avoid bleeding should be 
considered, including the choice of access site. The radial access has been associated with less 
access site bleeding (23, 24). Table 3 summarises access site complications. Other procedure-
related complications include allergic reactions, due to nonionic iodinate contrast media, with 
a rate of 0.1-0.7% (73-75) and contrast induced nephropathy (CIN). CIN, defined as a serum 
creatinine raise of  >25% above baseline or >44µmol/L 48h after contrast administration, has 
an overall incidence of <2%, but has at least a 10-fold higher incidence in high-risk patients i.e. 
in patients with diabetes mellitus, pre-existing renal impairment or heart failure (76). Various 
arrhythmias may occur during CA and PCI, most likely ventricular premature beats that are 
related to catheter placement during ventriculography. Ventricular tachycardia or ventricular 
fibrillation can follow prolonged intracoronary contrast injections and are reported in 0.1% 
(62). Furthermore, radiation exposure entails adverse effects, partly as direct radiation-induced 
injuries, but also by increasing the exposed´s life-time cancer risk (77, 78). Figure 3 depicts an 
overview of procedure-related complications in SCAAR in 2014 (16).
Table 3.  Comparison of access site complications according to puncture site. 
Radial Access Femoral Access
Vascular 
access site 
complications
0.2-0.5% (24, 34, 79)
Radial artery spasm (2-22%) (19)
Radial artery occlusion (1.5-33%) (19)
Radial artery perforation (1%) (80)
Pseudoaneurysm (~1%) (81)
AV fistula (0.2-0.4%) (19)
Radial artery avulsion (*) (19, 82)
Acute hand ischemia (*) (14)
0.5-0.7% (24, 62, 68)
Femoral artery thrombosis/occlusion (0.2%) (68) 
Dissection (< 0.1%) (68)
Pseudoaneurysm (0.3-7%) (68, 83)
AV fistula (1%) (84)
 Bleeding Puncture site (0.8%) (24)
Forearm haematoma (~1%) (81)
Compartment syndrome 
(<0.5%) (85, 86)
Puncture site (1.8%) (24, 87)
Retroperitoneal bleeding (0.74%) (88)
Others, 
very rare
Sterile granuloma (*) (19)
Catheter entrapment (81) 
Radial nerve injury (*) (19)
(*) case reports
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Procedure-related stroke or TIA in patients undergoing CA and PCI
Procedure-related neurological complications consist mainly of stroke and TIA. But also 
other neurological symptoms such as migraine, sedative-induced delirium (89), seizures, 
confusions, conditions related to cerebral hypoperfusion and peripheral nerve injury are 
reported to occur during coronary procedures (Study III). Thus, the term neurological 
complications may not only comprise procedure-related stroke or TIA. 
Procedure-related stroke is rare with an incidence ranging between 0.1 and 0.3 % for CA (89, 
90) and 0.1-0.4% for PCI (42, 91, 92) and the rate is influenced by the definition and by the 
study type.  Single centre studies with specific neurological assessment and comprehensive 
use of brain imaging techniques tend to report somewhat higher incidence (91, 93). Several 
factors are known to be associated with an increased risk for procedure-related stroke. Those 
can be categorised as patient-related (previous stroke, previous CABG, renal failure) (91, 92, 
94, 95), situation-related (urgent, STE-ACS or NSTE-ACS) (92, 94, 95) and technical aspects 
(number and size of the catheters, fluoroscopy time) (89, 93). The impact of the vascular 
access site on procedure-related stroke or TIA as a primary endpoint has been assessed in 
register-based studies without showing significant differences between the femoral and 
radial access site (42). Prospective randomised trials, conducted to compare morbidity and 
mortality, mainly in patients with ACS, between access sites, also did not report significant 
differences in procedure-related stroke (37, 40). To date, no randomised controlled trial has 
been specifically designed to answer this question.
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Figure 3. Overview of procedure-related complications in PCI patients, reported from the 
catheterisation lab in SCAAR 2014 (number of complications above the bar, 95 % CI) (20).
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Clinical silent cerebral ischemic lesions and CA and PCI
In contrast to the low incidence of procedure-related stroke or TIA after CA and PCI, 
cerebral microemboli have frequently been observed during various cardiac procedures with 
transcranial Doppler technique (27, 96, 97). Cerebral microemboli can consist of air bubbles, 
fat emboli, atheromatous material or blood clots (98) and have been related to new ischemic 
lesions found on cerebral magnet resonance imaging (MRI) with diffusion-weighted imaging 
(dw) sequences (27, 99). Silent brain infarcts lack stroke-like symptoms but can cause 
subtle neurological deficits such as depressive symptoms, visual field deficits, arm and leg 
disturbances and frailty (100). To date no standard definition for “silent” infarction exists, 
thus a silent infarction might be a cerebral infarction that was unnoticed or overlooked as 
well as an “asymptomatic” patient who may have mild facial paresis or reflex abnormity 
(101). Although their clinical impact is undecided, silent ischemic lesions have been linked 
to cognitive impairment and to increasing the risk for dementia (27, 100). 
Mild cognitive impairment 
Mild cognitive impairment (MCI) is a preclinical stage of dementia on the continuum of 
cognitive decline from normal ageing to dementia with a prevalence of 10-20% for adults 
over 65 years of age (102). In contrast to dementia, activities of daily living are preserved 
(102). Besides increasing age and male gender, further risk factors have been identified such 
as low educational level, vascular risk factors (hypertension and diabetes mellitus), vitamin 
D deficiency, sleep apnoea and previous critical illness (102). A higher educational level 
has been associated with a lower prevalence of dementia perhaps through increasing the 
cognitive reserve (103, 104). The risk for conversion from MCI to dementia is estimated to 
be between 2-20% depending on the population studied (105).
Background summary
CA and PCI are commonly used for diagnosing and treatment of patients with coronary 
artery disease. Overall, the procedure-related complication rate is 0.1-5% (60-62, 106), with 
0.1-0.4% procedure-related stroke or TIA (89, 91, 92). The occurrence of procedure-related 
silent ischemic cerebral lesions, associated with cognitive decline (27, 100), is significantly 
higher (2-35%) (107) and related to cerebral microemboli (27, 99, 108). Different techniques 
exist for CA and PCI including the choice of access site.  The radial access, increasingly used 
over time, is shown to be beneficial for patients with STE-ACS, as access related bleedings 
are significantly reduced compared with the femoral access, resulting in lower mortality for 
this patient group (25). Notwithstanding those advantages, the relation between vascular 
access site and procedure-related stroke or TIA and silent ischemic cerebral lesions are not 
thoroughly studied.  Furthermore, evidence regarding how to advance the guidewire when 
using the femoral access is lacking. With an ageing population, minimising the risk for overt 
and silent ischemic cerebral lesions is relevant. The choice of technique used for diagnostic 
and interventional procedures which carry the lowest risk for neurological complications is 
of importance. The purpose of this thesis was to scrutinise these gaps of knowledge.
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AIMS
The aim of this thesis was to investigate if different techniques used for CA and PCI influence 
the occurrence of procedure-related ischemic cerebral complications. 
The specific aims of the studies were to investigate:
1. if the number of cerebral microemboli in the middle cerebral arteries differs when the 
radial and femoral access are used during CA in patients with stable angina pectoris 
(Study I).
2. if the number of cerebral microemboli in the middle cerebral arteries differs between 
two techniques used for CA with the femoral access, where catheters are advanced 
with or without a leading guidewire over the aortic arch (Study II).
3. retrospectively, if the vascular access site used for CA or PCI is associated with pro-
cedure-related stroke or TIA (Study III). 
4. if cognitive function is impaired after CA or PCI and to explore its possible relation-
ship to the number of cerebral microemboli detected in the middle cerebral arteries 
and the vascular access site used (Study IV).
          Cardiac catheterisation and procedure-related cerebral complications
21
METHODS
Study groups
This thesis is based on four studies which evaluate the different techniques used for CA 
and PCI regarding procedure-related ischemic cerebral lesions in patients with suggested 
or established CAD. As described in Figure 4 in Studies I, II and IV 185 patients were 
prospectively enrolled.  Using a register, in Study III 336,836 CA and PCI procedures, 
corresponding to 255,609 individual patients, were assessed retrospectively.
Study I, a prospective randomised trial, included 51 patients with stable angina pectoris, who 
had been referred for diagnostic CA to the Karolinska University Hospital/Solna between 
February 2007 and June 2008. Exclusion criteria were valvular heart disease, previous 
CABG, a pathological Allan´s test (collateral circulation of the right radial artery (109)), 
advanced kidney disease with an estimated glomerular filtration (eGFR) rate below 30 ml/min 
(Cockroft-Gault formula), and if both middle cerebral arteries (MCAs) were not detectable 
with TCD. All patients were treated with aspirin prior to CA.
After randomisation to the radial or femoral access, the CA procedure was divided into 6 
predefined steps reflecting catheter exchange and engagement of the coronary ostia (Table 4). 
CA was performed by two interventional cardiologists with one catheter for the right and one 
for the left coronary artery, respectively. When the radial access was used a pharmacological 
“cocktail” consisting of 5,000 IU heparin, 250 µg glycerylnitrate, and 2.5 mg verapamil 
hydrochloridium in 15 ml of saline was injected into the 6 Fr Flexor Radial sheaths (Cook 
Group Inc., Bloomington, IN, USA). Directly after its insertion 6 Fr JL 3.5 and JR 4 catheters 
 
Vascular access site for CA, PCI
microemboli stroke/TIA             cognitive function 
CA catheter
advancement 
microemboli
Study I
n= 51
Study III
n=336,836*
Study IV
n= 93
Study II
n=41
Prospective
RCT
Retrospective
Register study
Prospective
RCT
Prospective
RCT
Figure 4. Studies included in this thesis.
*= procedures
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(Boston Scientific Corp., Boston, MA, USA) were advanced to the valsalva sinus and 
exchanged over the wire using 0.035” 250 cm guidewires (Cordis Corp., Fremont, CA, USA). 
For the femoral access Ultimum 6 Fr sheaths (St. Jude Medical Inc., ST. Paul, MN, USA) were 
used, 6 Fr JL and JR 4 catheters (Boston Scientific Corp., Boston, MA, USA) and 0.035” 150 
cm guidewires (Boston Scientific Corp., Boston, MA, USA) were advanced to the ascending 
aorta. Prior to use, all catheters and guidewires were heparinised. All patients received a 
standard contrast medium Visipaque 320 mg/ml® (GE Healthcare, Little Chalfont, UK). 
Fluoroscopy time and delivered contrast volume were recorded. Simultaneously, cerebral 
microemboli were measured with the transcranial Doppler (TCD) technique, whereby both 
the right and the left MCA were insonated. Additionally, with help of a synchronised clock, 
the TCD recording was correlated to the predefined stages of the CA procedure.  
Study II, a prospective randomised trial, included 41 patients with stable angina pectoris or 
non-ST-segment elevation acute coronary syndrome (NSTE-ACS), who had been referred 
for CA to the Karolinska University Hospital/Huddinge. Exclusion criteria were ST-segment 
elevation myocardial infarction (STEMI), advanced kidney disease with eGFR below 30 ml/
min (Cockroft-Gault formula) and if both MCAs were not detectable with TCD.
CA was performed with the femoral access using similar sheaths, guidewires, catheters and 
contrast medium as described for the femoral access in Study I. The study protocol comprised 
of two parts: part one consisted of catheter and guidewire advancement including diagnostic 
Table 4. Procedural stages of the CA.
Procedural stage Practical implementation
1.  Arterial access •	 Insertion and flushing of the introducer
2.  Insertion of the first catheter •	 Insertion of the guidewire*
•	 Insertion of the catheter 
•	 Removal of the guidewire 
•	 Withdrawal of blood and flushing of the catheter
3. Coronary angiography •	 Engagement of the coronary ostium
•	 Contrast delivery 
4. Exchange of the catheters •	 Disengagement of the catheter
•	 Introduction of the guidewire
•	 Removal of the first catheter
•	 Insertion of a new catheter
•	 Removal of the guidewire
•	 Withdrawal of blood and flushing of the catheter
5. Coronary angiography •	 Engagement of the coronary ostium
•	 Contrast delivery 
6. Removal of the guidewire and the 
catheter
•	 Disengagement of the catheter
•	 Introduction of the guidewire
•	 Removal of the guidewire and the catheter 
(*) with the femoral access the guidewire and the catheter were inserted together
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CA followed by part two, where only catheters and guidewires were advanced as opposed to 
part one. In part one, patients were randomised to either catheter and guidewire advancement 
in the ascending aorta or to withdrawal of the guidewire in the descending aorta, and catheter 
advancement alone over the aortic arch. Following this protocol, both techniques were used 
in each patient; the randomisation was used to ensure an equal chance for either technique 
to start with. The study protocol is depicted in Figure 9. Independent of randomisation, more 
than 10 ml of blood was aspirated and discarded and all catheters were flushed with 20 ml 
of heparinised saline. Ventriculography, aortography, intracoronary pressure measurement or 
PCI were performed when indicated, but always after the study protocol was accomplished. 
Cerebral microemboli were detected using TCD in a similar setting as described in Study I.
In Study III all CA and PCI procedures performed between 2003 and 2011 listed in the 
Swedish Coronary Angiography and Angioplasty Registry (SCAAR) with information on 
access site were assessed retrospectively regarding the occurrence of procedure-related 
neurological complications. To increase the accuracy of the outcome variable, medical 
records of the patients, in whom a neurological complication had been reported, were 
collected from the treating hospitals, reviewed by two independent neurologists, and 
determined to be procedure-related if the onset was within 24h of the procedure in the 
absence of atrial fibrillation. Neurological complications were categorised as stroke or TIA 
(ischemic stroke and intracerebral haemorrhage but not subarachnoid haemorrhage), other 
neurological complications or no neurological complication. Including centre experience 
(with experienced centre defined as when more than 50% of the procedures were performed 
with the radial access per year), data on co-morbidity from SCAAR and the National Patient 
Register (NPR), a regression analysis was performed to determine the Risk Ratio (RR) for 
procedure-related stroke or TIA of the radial access compared with the femoral access.
Study IV, a prospective randomised trial, included 93 patients with stable angina pectoris who 
had been referred for CA or PCI at the Karolinska University Hospital between September 
2011 and March 2012. Exclusion criteria were previous CABG, advanced kidney disease 
with an eGFR below 30 ml/min (CKD-epi formula), a pathological Allan´s test and language 
difficulties in Swedish. 
Patients were randomised to either the radial or femoral access site and their cognitive 
function was assessed repeatedly with help of the Montreal Cognitive Assessment (MoCA). 
The baseline test was executed before the procedure, while the first and the second follow-
up MoCA tests were scheduled for 3 and 30 days, respectively, after the procedure. In a 
subgroup of 35 patients cerebral microemboli were registered with TCD during the CA or 
PCI procedure in a similar setting as described in Studies I and II. 
Transcranial Doppler and microemboli detection
The transcranial Doppler (TCD) technique is a noninvasive ultrasound method for 
measurement of blood flow velocity in cerebral arteries based on the principle of the Doppler 
effect. Introduced in 1982 by Aaslid (110) to detect intracranial vasospasm in patients 
with subarachnoid haemorrhage, it is still used for this purpose. Other clinical applications 
include diagnosis of cerebrovascular ischemia (steno-occlusive disease, acute ischemic 
stroke), monitoring of blood flow velocity, and assessment of intracranial arteriovenous 
malformations, cerebral microemboli, and cerebral circulatory arrest (111).
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Ultrasound waves are emitted from the probe, transmitted through the skull and reflected 
by moving red blood cells within the cerebral vessels.  The difference between the emitted 
and reflected waves is referred to as the Doppler shift frequency. For the TCD measurement, 
a 2 MHz frequency ultrasound probe was used (Embodop®, DWL, Singen, Germany), to 
allow penetration through thinner regions of the skull. The trans-temporal window enables 
the identification of the intracranial carotid artery bifurcation, after which the middle cerebral 
artery (MCA) can be insonated by a flow direction towards the probe (111, 112).
Ultrasound waves are deflected by microemboli and emerge as high-intensity transient signals 
(HITS). The multi-frequency technique enables automatic differentiation, as the backscatter 
of gaseous and particulate microemboli are different; i.e. particulate emboli reflect more 
ultrasound at the higher than at the lower frequency, whereas it is the opposite for gaseous 
microemboli, Figure 5 (113-115). 
Figure 5. Display of TCD with MCA and HITS. 
The upper panels on the left side show the pulse wave of the left middle cerebral artery 
(A) and the right middle cerebral artery (B). Occurrence of high-intensity transient signals 
(HITS) is shown in the upper panel, marked with asterisk (*). Their differentiation is shown 
in the lower panel as artefacts (blue dots), gaseous (green dots), and particulate (red dots) 
microemboli.
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In Studies I, II and IV a multi-frequency TCD was used. The detection level for microemboli 
was set as a 7 dB or greater increase above background level (embolus blood ratio [dEBR]) 
that lasted 4 ms or longer simultaneously in both 2.0- and 2.5-MHz frequency channels. The 
MCAs of the patients were detected at a depth of 40 to 55 mm. The sample volume was 13 
mm, no filter, a power of 200 mW, and a scale of 80 cm/s was applied. To facilitate online 
rejection of artefacts a reference gate was set 15 mm superficial to the MCA insonation gate. 
Transcranial Doppler monitoring was recorded continuously from start of sheath insertion 
and until the final catheter had been withdrawn, emboli were automatically counted and 
differentiated into particulate and gaseous and in Studies I and II correlated to predefined 
procedural steps during CA (111, 113-115).
  
Registers
The Swedish Coronary Angiography and Angioplasty Registry (SCAAR), established 1998 
and exclusively supported by Swedish Health Authorities, is part of the nationwide internet-
based Swedish Web system for Enhancement and Development of Evidence-based care in 
Heart disease Evaluated According to Recommended Therapies (SWEDEHEART) register. 
All 30 centres performing CA and PCI in Sweden report every procedure directly on-line to 
the register. SCAAR contains information about patient characteristics, indications for CA 
and PCI, procedural details, choice of intervention as well as outcome data. Since 2001 data 
from all hospitals are verified by comparing 50 entered variables in 20 randomly selected 
interventions per hospital and year with the patients’ hospital records, with an overall 
correspondence of 95.2% (116). SCAAR was used in Study III, where all CA and PCI 
procedures performed between 2003 and 2011 were assessed and included in the analysis if 
their vascular access site was recorded. 
The Swedish National Patient Register (NPR) has complete nationwide coverage and was 
used in Study III to acquire data on co-morbidity used in the regression analysis. By merging 
SCAAR data with NPR at the time of the procedure, primary and secondary International 
Classification of Diseases, tenth revision codes (ICD-10) were obtained from 1997 until 2010.
Montreal Cognitive Assessment
The Montreal Cognitive Assessment (MoCA) test is a screening tool with good sensitivity 
(80-100%) and specificity (50-76%) compared with neuropsychological tests for detection 
of mild cognitive impairment (117, 118). The MoCA test assesses major cognitive domains 
such as visuospatial / executive function, naming, memory, attention, language, abstraction, 
delayed recall, and orientation in 10 to 15 minutes, is easy to administer and to interpret. 
To minimise the learning effect from multiple testing, we used the MoCA test in Study IV 
serially with two different versions, with permission from the author.
Endpoints
In Studies I and II the primary endpoint was the number of cerebral microemboli.  The 
primary endpoint in Study III was procedure-related stroke or TIA. In Study IV cognitive 
impairment was the primary endpoint, whereas the relation to cerebral microemboli and to 
vascular access site were secondary and tertiary endpoints, respectively. 
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Figure 6. The MoCA test, Swedish version (118a).
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Statistical methods
Numerical non-normally distributed data were presented as medians and interquartile ranges 
(IQR) and compared with the Mann-Whitney U-test (Study I, II, IV) such as the number 
of cerebral microemboli or the difference in MoCA test results between access site groups. 
More than two groups were compared with the Kruskal-Wallis test (Study II). Categorical 
data such as baseline characteristics were compared with the χ2 test and Fisher´s exact test 
(Study I). For pairwise comparison the Wilcoxon signed-rank test was used (Study II, IV). 
Correlation analysis between the number of cerebral microemboli and difference in MoCA 
test results between baseline and follow up was performed with the Spearman rank test 
(Study IV). In Study III, associations between verified procedure-related stroke or TIA and 
predefined clinical variables were estimated using a generalised estimating equation (GEE) 
model with an autoregressive correlation matrix to allow for possible dependence in repeated 
procedures on the same patient.  Multiple imputation using predictive mean matching was 
applied when data were missing. Additionally, a propensity score for vascular access site was 
estimated for each procedure and included in another GEE model together with access site. 
All statistical tests were two-tailed with a significance level of 0.05.  Statistical Package for 
Social Science (SPSS) version 17 (SPSS Inc., Chicago, IL, USA), versions 19 and 22 (IBM 
corp., Armonk, NY, USA) were used for data analysis in Study I, II and IV, respectively. For 
Study III all analyses were performed using R version 3.1.3 (R Foundation for Statistical 
Computing, Vienna, Austria).
Ethical considerations
All studies were approved by the local ethics committee (Stockholm and Uppsala), conformed 
with the Declaration of Helsinki, and followed the principles of good clinical practice. All 
patients in Studies I, II, IV obtained more detailed information about CA techniques and 
risk for procedure-related complications, especially neurological complications. All patients 
provided written informed consent. Being a study patient implied to waive preference to 
vascular access site, limited head movement during the cardiac catheterisation due to TCD 
recordings and in Study IV time consuming extra hospital visits. Furthermore, in Study 
II additional catheters and guidewires were used, implying a small but potential risk for 
complications and prolonged catheterisation procedures compared with standard care. As 
in Study I and IV disadvantages for the patients mainly comprised modest discomfort and 
in Study II the additional complications risk was estimated to be low, the expected benefits 
outweighed the study related risk, in the light of gaps in evidence-based knowledge regarding 
the impact of catheter techniques on potentially harmful cerebral embolisation.
In Study III patients were informed about the inclusion in a register (SCAAR) and had the 
right to decline participation, but did not provide written informed consent. The merge of the 
registries used in Study III was approved by the National Board of Health and Welfare. In 
order to verify procedure-related stroke or TIA, medical records were collected and analysed 
by two neurologists. As further analysis was performed with anonymised data only, the 
possible risk of revealing confidential medical records was minimised and considered to be 
outweighed by the benefit of validated data. 
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RESULTS AND DISCUSSION
Study I 
The hypothesis in Study I was that the number of cerebral microemboli in the MCAs differs when 
the radial and the femoral access site are used for CA in patients with stable angina pectoris.
Of the 340 patients screened, 263 patients did not meet inclusion criteria and 26 patients were 
not included due to other reasons. Hence, a total of 51 patients were included in the study and 
randomised to the radial (n=28) or the femoral (n=23) access site. In the radial group 8 patients 
were converted to femoral access and excluded from the final analysis. Thus, the statistical 
analysis included 20 patients in the radial group and 23 patients in the femoral group. Baseline 
characteristics and results for the study cohort are shown in Table 5. Patients in the femoral 
access group were more likely to have diabetes mellitus and one- or two-vessel disease on CA. 
Table 5. Baseline characteristics and results
Angiography via  
right femoral artery
n=23
Angiography via 
right radial artery
n=20
p-value
Age 66.3±7.6 61.6±8.8 0.08 
Women 4 (17) 2 (10) 0.67 
Hypertension 16 (70) 12 (60) 0.51 
Diabetes mellitus 12 (52) 2 (10) 0.004 
Prior stroke/TIA  4 (17) 2 (10) 0.68 
Prior acute myocardial infarction  3 (13) 4 (20) 0.68 
Prior percutaneous coronary intervention  3 (13) 4 (20) 0.69 
Number of coronary stenoses:  
No stenosis 5 (22) 12 (60) 0.03
1-VD 12 (52) 3 (15)
2-VD 4 (17) 2 (10)
3-VD 2 (9) 3 (15)
Contrast volume (ml) 75 (60-100) 82.5 (50-160) 0.31
Fluoroscopy time (min) 2.5 (1-5) 6 (2-12) <0.0001
Number of gaseous microemboli 44 (7-131) 58 (19-469) 0.08
                       Right MCA 19 (1-69) 32 (11-171) 0.003
                       Left MCA 21 (6-85) 23.5 (3-298) 0.44 
Number of particulate microemboli 6 (1-19) 10 (1-120) 0.02
                       Right MCA 2 (0-9) 7 (1-65) 0.004
                       Left MCA 3 (0-15) 3 (0-55) 0.57
Values are mean±SD, numbers (%) or median (min-max range). MCA= middle cerebral artery, VD= vessel disease.
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In 2 patients in the radial and femoral group, respectively, additional catheters were used to 
cannulate the coronary ostia. Microemboli detected during these additional procedural stages 
were excluded from the statistical analysis. 
No vascular complications or clinical overt neurological complications were observed during 
hospital stay.
Cerebral microemboli occurred during all CAs without significant diversity between the 
operators. There were significantly more particulate cerebral microemboli detected in the 
radial compared with the femoral group (Table 5, Figure 7). When the right and left MCA 
were analysed separately, significantly more particulate cerebral microemboli passed the 
right MCA with the radial compared to the femoral access, whereas there was no difference 
between the access site groups regarding the left MCA (Table 5). Also more gaseous 
microemboli were observed in the right MCA with the radial access, but unlike particulate 
microemboli, overall their number did not differ between the access sites (Table 5).
When different angiographic procedural steps were analysed, the count of particulate 
cerebral microemboli in both MCAs was higher during catheter exchanges compared with 
examination of the coronary arteries (7 (0-51) versus 1 (0-67), p<0.001). When catheter 
exchanges were evaluated separately for left and right MCA, more cerebral microemboli 
were detected in the right MCA with the radial compared with the femoral access, Figure 8. 
Likewise, during coronary artery examination more cerebral microemboli were identified in 
the right MCA with the radial access, Figure 8. 
Discussion
In this randomised study the number of cerebral microemboli was compared between vascular 
access sites. Cerebral microemboli were detected during all CA procedures, but more particulate 
cerebral microemboli were identified when the radial access was used. A higher count of 
Figure 7. Number of particulate cerebral 
microemboli during coronary angio-
graphy for femoral and radial access site
Figure 8. Number of particulate cerebral 
microemboli during coronary angiography 
divided into procedural stages of catheter 
exchange and coronary examination, for the 
right and left middle cerebral artery (MCA), 
respectively, for femoral and radial access site
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cerebral microemboli with the radial access during CA and PCI has previously been shown 
in a non-randomised study (27). Lund and co-workers also linked cerebral microemboli to 
new ischemic lesions on diffusion-weighted MRI (27). By contrast, a randomised study 
including patients with aortic stenosis examined with CA did not show a significant difference 
in new ischemic lesions with diffusion-weighted MRI according to access site, but was under-
powered as admitted by the authors (119). The comparability to our study is limited since only 
a subgroup of the study patients were examined with TCD (119). 
Compared with other procedural steps, a higher number of cerebral microemboli were 
observed during catheter exchange for both access sites, but most emboli were detected in the 
right MCA with the radial access. The reason could be the passage of anatomical structures: 
catheters and guidewires need to be advanced from the right radial-, brachial- and subclavian 
artery via the brachiocephalic trunk and bend sharply into the ascending aorta on their way 
to the coronary ostia, which may disrupt atherosclerotic plaques adherent in the vessel wall. 
This hypothesis needs to be proven as no data on atherosclerosis of the aortic arch were 
available in our study cohort. However, in support of this concept Pacchioni and co-workers 
showed that the number of cerebral microemboli was lower when the left, compared to the 
right, radial access was used (120). Aiming to reduce the number of cerebral microemboli 
with the radial access, the use of only one diagnostic catheter for the examination of both 
coronary arteries should be favourable. Indeed, Pacchioni and co-workers recently showed 
that using two diagnostic catheters compared with a single one almost doubled the number of 
microemboli detected performing CA with the right radial access (121).  
Our study has several limitations. The crossover rate from the radial to the femoral access 
was higher than expected. However, those patients were excluded from the analysis. The 
operators were experienced with both access sites and as the low number of additional 
catheters show, they changed access site rather than trying additional catheters. Moreover, as 
already mentioned, most cerebral microemboli were detected in operator independent stages 
such as catheter insertion and exchanges. The fluoroscopy time was longer in the radial access 
group, implying a potential confounder due to longer contact time of the catheters within the 
vessels. Even though the difference in fluoroscopy time has been reduced over time, the 
radial access is still associated with higher radiation exposure (19, 33). Despite the higher 
risk for stroke due to the absence of additional heparin use and the higher co-morbidity, such 
as diabetes mellitus and severe CAD, less cerebral microemboli were detected in the femoral 
group. 
In summary cerebral microemboli occurred frequently during diagnostic CA. The number 
of particulate cerebral microemboli was higher when the radial access was used. That 
microemboli were mainly detected during catheter exchanges and predominantly in the right 
MCA with the radial access indicates a causal relationship.
Study II 
The hypothesis of Study II was, that the number of cerebral microemboli differs according 
to guidewire techniques used with the femoral access: catheter advancement over the aortic 
arch with or without the help of a guidewire.
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Of the 102 patients screened 44 were included in the study. Ultimately, 41 patients were 
analysed due to incomplete TCD recordings in three patients. Thus, 21 patients were 
randomised to initial advancement of the catheters with a guidewire over the aortic arch and 
flushing of catheters in the ascending aorta (group A), and 20 patients to initial guidewire 
withdrawal and flushing of catheters in the descending aorta (group B), Figure 9. Baseline 
characteristics are shown in Table 6. The majority of the patients were treated with aspirin 
and clopidogrel, and half of the patients with fondaparinux, due to a preliminary diagnosis 
of NSTE-ACS. In two cases the final diagnosis of NSTE-ACS and the treatment given were 
divergent due to changed diagnosis and missed administration. Patients with stable CAD did 
not receive heparin. No overt stroke or TIA was observed before patient discharge. 
CAs were performed by six interventional cardiologist. Procedure times for part 1 and part 2 
did not differ between group A and group B (Table 6). No reinsertion of the catheters due to 
twisting or bending was necessary.
Cerebral microemboli were detected in all patients, without significant differences dependent 
on operator. Their count did not differ according to whether it was the right or left MCA, 
extend of vessel disease or use of fondaparinux. More particulate and gaseous cerebral 
Figure 9. Study design. 
TCD= transcranial Doppler
Assessed for eligibility
n= 104
Not meeting inclusion criteria
n= 60
Included
n= 44
Allocated to guidewire withdrawal
in the ascending aorta
n= 23
New guidewire withdrawal in
the descending aorta
n= 23
Analysed
n= 21
2 excluded, incomplete TCD
Part 1
TCD
Part 2
Allocated to guidewire with-
drawal in the descending aorta
n= 21
New guidewire withdrawal in
the ascending aorta
n= 21
Analysed
n= 20
1 excluded, incomplete TCD
TCD
Group A Group B
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Table 6. Patient characteristics and diagnostic results.
Group A n=21 Group B n=20
Age 62 ± 10 60 ± 7
Women 5 5 
Smokers 6 1 
Hypertension 10 12 
Diabetes mellitus 4 5 
Prior Stroke or TIA 1 2 
Peripheral vascular disease 1 1
Prior MI 5 2 
Prior PCI 4 2 
ASA 21 18 
Clopidogrel 19 18 
Fondaparinux 12 10 
Warfarin 0 2 
Discharge diagnosis
Stable angina pectoris 8 11 
NSTE-ACS 13 9 
Angiographic results
0 8 9 
1 VD 7 7
2 VD 2 2 
3 VD 4 2 
Procedure time
Part 1 10:06 (06:52) 10:22 (02:59)
Part 2 03:32 (00:37) 03:21 (00:38)
Number of particulate cerebral 
microemboli
Part 1 ASC 9 (9) DESC 3 (5) 
Part 2 DESC 0 (2) ASC 2 (7)
Number of gaseous 
cerebral microemboli
Part 1 ASC 48 (51) DESC 27 (31)
Part 2 DESC 4 (12) ASC 31 (44)
Values are presented as mean ± SD and median (IQR). Procedure time in minutes: seconds (IQR). 
ASC= guidewire withdrawal in ascending aorta (ASC), DESC = guidewire withdrawal in descending 
aorta, MI = myocardial infarction, NSTE-ACS= non-ST-segment elevation acute coronary syndrome, 
PCI = percutaneous coronary intervention, VD= vessel disease. 
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microemboli were identified when the catheters were advanced with a leading guidewire 
over the aortic arch compared with when the guidewire was withdrawn in the descending 
aorta and the catheter was advanced alone over the aortic arch, Figure 10.
As part 1 included a complete coronary examination, more cerebral microemboli were 
detected in part 1 compared to part 2; particulate 6 (8) versus 1 (3), (p<0.001) and gaseous 34 
(35) versus 13 (29), (p<0.001), respectively. 
Sub-analyses of parts 1 and 2, respectively, showed more particulate (Figure 11) and gaseous 
cerebral microemboli (Table 6) with the ascending technique, compared with the descending 
technique.
Figure 10. Total number of cerebral microemboli detected with transcranial Doppler 
(TCD), independent of allocation group. Guidewire withdrawal in the ascending aorta 
(ASC) and descending aorta (DESC) for (A) particulate cerebral microemboli and (B) ga-
seous cerebral microemboli. Data given as median (interquartile range).
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Figure 11. Number of particulate cerebral microemboli detected with transcranial Doppler 
(TCD) during part 1 and part 2 of the procedure. Number of particulate cerebral microemboli 
detected when the guidewire was withdrawn in the ascending aorta (ASC) compared with 
guidewire withdrawal in the descending aorta (DESC) during part 1 (A) and part 2 (B) of the 
study. Data given as median (interquartile range). 
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Discussion
By comparing two guidewire techniques this study showed that more cerebral microemboli 
were generated when catheters are advanced with a protruding guidewire to the ascending 
aorta compared with advancement of the catheter alone after withdrawal of the guidewire 
in the descending aorta. Our findings are in line with a previous study by Breakken and co-
workers, but in their study microembolisation was assessed only on the left MCA and no 
differentiation into gaseous and particulate emboli was possible (122). It is reasonable that 
particulate cerebral microemboli have different origins. Atherosclerotic plaques in the aortic 
arch have been shown to be highly prevalent in a comparable patient cohort (123). To avoid 
contact between the edges of the catheter and the aortic wall, Judkins modified the shape of 
the catheter to be atraumatic by changing the catheter tip to a “bullet nose“ configuration and 
by pointing the edge of the catheter to the rear (7). Contrary to this approach, when a catheter 
is straightened by a guidewire, the edge may scrape the vessel wall when advanced over the 
aortic arch. Indeed, the occurrence of dislodged aortic debris in catheters advanced with a 
guidewire has previously been reported (124, 125). 
One could argue that a catheter without a leading guidewire is more difficult to engage 
the coronary orifices. Due to prolonged procedure durations the risk for embolisation may 
increase as catheters are recognised highly prothrombotic materials (9, 126). However, none 
of the 6 interventional cardiologists reported those difficulties, supported by equal procedure 
times for both techniques. 
Our study has several limitations. The sample size was small, but by applying a crossover 
model, the sample size doubled as both techniques were used in the same patient. Due to the 
case-mix of stable angina and ACS patients, different atherosclerotic plaque formation may 
have an impact on cerebral microemboli detected. However, no difference in the number of 
cerebral microemboli between patients treated with and without fondaparinux was found. 
No cognitive assessment was part of the study, thus leaving the clinical impact of the above 
findings unexamined.
In summary, more cerebral microemboli were detected when the catheter was advanced 
with the help of a protruding guidewire to the ascending aorta compared with catheter 
advancement alone and guidewire withdrawal in the descending aorta. The latter technique 
is easy to execute during CA and should be considered in patients at high-risk of ischemic 
neurological complications.
Study III 
The hypothesis in Study III was that the occurrence of procedure-related stroke or TIA 
differs between the radial and the femoral access site used for CA and PCI when adjusted for 
confounding factors.
In this retrospective register study 336,836 procedures were included for analysis, after 
exclusion of 3,907 procedures with missing or unknown access site. In total, 127,746 radial 
and 209,090 femoral procedures were examined, whereof the majority, 255,609 (75.9%) were 
performed in unique patients. Over time, the radial access was increasingly used, from 20% 
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to 70% between 2003 and 2011. The stroke or TIA rate per year did not change significantly 
over time. Access site crossover was recorded in 6,430 procedures, mainly from the radial to 
the femoral access (94%). In the radial access group normal CA findings or 1-VD were more 
likely, while a higher degree of VD and other cardiovascular co-morbidities were more likely 
in the femoral access group. Within 24h from the procedure 2,037 patients died: 377 in the 
radial and 1,600 in the femoral access group, respectively. 
After review, 546 reported neurological complications were verified as being procedure-
related stroke or TIA, whereof 183 were considered TIA. This corresponds to an incidence of 
0.16% and did not change substantially over time. Table 7 shows univariate and multivariate 
risk factors for procedure-related stroke or TIA. In crude analysis the radial access was 
not associated with a higher risk for procedure-related stroke or TIA. In contrast, after 
multivariable adjustment the risk ratio (RR) for procedure-related stroke or TIA was 1.30 
(CI 1.04-1.62), p= 0.022 for the radial access (Table 7). Those findings were not significantly 
changed after exclusion of crossover procedures RR 1.27 (CI 1.01-1.60), p=0.039 or 
exclusion of procedures where patients died within 24h, RR 1.32 (CI 1.05-1.65), p=0.016. 
When adjusting for the propensity score RR was 1.23 (CI 0.99-1.53), p=0.057.
Subgroup analysis revealed a significant interaction between the group of ACS/ no ACS 
and access site with a higher risk for procedure-related stroke or TIA in ACS patients with 
the radial compared with the femoral access. Though there was an absence of significant 
interaction between time interval and access site, during 2009 and 2011 the procedure-related 
stroke or TIA risk was considerably higher with the radial access. 
 
Discussion
In this register study the radial access was associated with a 30% higher risk for procedure-
related stroke or TIA compared with the femoral access. 
To our knowledge this is the first large-scale retrospective study where the reported 
neurological complications were verified to be procedure-related. By this, the incidence of 
stroke or TIA was 0.16%, which is in line with other contemporary register studies (41, 92, 
94, 127). Higher incidences (0.4%) have been reported by single centre studies, possibly 
due to the presence of a neurologist on site and the comprehensive use of brain imaging 
techniques making the report of neurological complications more likely (93, 128). 
Our findings are contrary to a recently published register study by Ratib and co-workers 
who did not find a higher risk for procedure-related neurological complication according 
to access site (42). There are several differences when compared with our study: Ratib and 
co-workers assessed PCI procedures only whereas we included CA procedures as well. 
This may explain the lower prevalence of patients with previous CABG in their study (42). 
Another difference is the definition of procedure-related: while Ratib and co-workers used 
neurological complication before discharge, we aimed to ensure the relation to the procedure 
with a 24h time frame and the exclusion of atrial fibrillation (42). Moreover, our study cohort 
had higher prevalence of cardiovascular co-morbidity. 
In our study, patient characteristics according to access site were considerably different with 
a higher co-morbidity in the femoral group. We adjusted for previously known patient-related 
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Table 7.  Association between access site and periprocedural stroke or TIA
Crude Adjusted
Variable RR 95%CI p-value RR 95%CI p-value
Radial access 0.91 0.76-1.08 0.287 1.30 1.04-1.62 0.022
Age 1.05 1.04-1.06 <0.001 1.04 1.03-1.05 <0.001
Female sex 1.30 1.10-1.55 0.003 1.34 1.11-1.61 0.002
Year of procedure§ 0.95 0.92-0.98 0.001 0.94 0.90-0.97 0.001
Current smoking 0.68 0.53-0.88 0.003 0.88 0.67-1.16 0.378
Diabetes mellitus 1.47 1.21-1.79 <0.001 1.28 1.04-1.57 0.021
Hypertension 1.10 0.92-1.30 0.292 0.89 0.74-1.08 0.238
Hyperlipidemia 1.04 0.87-1.23 0.686 0.92 0.75-1.12 0.409
Renal failure 1.58 0.99-2.52 0.057 1.36 0.84-2.20 0.209
COPD 1.10 0.81-1.50 0.542 0.94 0.69-1.29 0.715
Peripheral vascular disease 1.89 1.39-2.58 <0.001 1.29 0.94-1.78 0.112
Previous stroke 1.98 1.54-2.56 <0.001 1.45 1.12-1.88 0.005
Heart failure 1.38 1.09-1.76 0.009 0.99 0.76-1.28 0.914
Previous MI 1.28 1.06-1.55 0.009 0.99 0.79-1.23 0.928
Previous CABG 2.33 1.90-2.86 <0.001 2.23 1.75-2.85 <0.001
Previous PCI 0.82 0.66-1.02 0.076 0.79 0.62-1.00 0.052
Expert centre 0.89 0.74-1.06 0.182 0.88 0.69-1.13 0.324
Procedure
PCI 0.31 0.16-0.60 0.001 0.25 0.13-0.49 <0.001
CA + PCI 1.14 0.97-1.35 0.121 0.88 0.72-1.09 0.258
Thrombectomy 1.33 0.90-1.97 0.157 1.24 0.82-1.86 0.306
Situation
ACS 1.61 1.36-1.92 <0.001 1.34 1.11-1.62 0.003
Findings
1-VD 1.69 1.29-2.21 <0.001 1.65 1.20-2.26 0.002
2-VD 2.02 1.52-2.66 <0.001 1.71 1.23-2.37 0.001
3-VD 2.57 1.99-3.31 <0.001 1.58 1.16-2.15 0.004
ACS= acute coronary syndrome, CA= coronary angiography, CABG= coronary artery bypass graft, 
COPD= Chronic obstructive pulmonary disease, MI= myocardial infarction, PCI= percutaneous 
coronary intervention, VD= vessel disease
§ year as continuous variable between 2003-2011
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risk factors for procedure-related stroke or TIA such as age, gender (94, 129), severity of 
CAD (89), previous stroke (91, 92, 94), previous CABG (94, 130) and procedure-related 
risk factors such as procedure during ACS (91, 92, 94) or thrombectomy (131). Since centre 
experience has been associated with patient outcome it was also included in the regression 
model (37, 40, 132). Besides centre experience and thrombectomy, all other known risk 
factors were confirmed in our analysis. That the radial access is associated with higher risk for 
procedure-related stroke or TIA remained significant after exclusion of crossover procedures, 
despite it having previously been reported that the number and size of catheters used was 
associated with higher procedure-related stroke risk (93). Similarly, when excluding patients 
dead within 24h from the procedure, the higher risk for procedure-related stroke or TIA with 
the radial access remained. When a propensity score was included in the main model, the point 
estimate supports the findings (RR 1.23), but with CI (0.99-1.53) which is strictly speaking 
not significant. It could be argued that the difference found in the multivariable analysis is 
due to chance, which is possible, but we did our best to adjust for several confounders and 
performed sensitivity analysis as described above.
Contrary to register studies, the incidence of periprocedural stroke in RCTs is generally 
higher (0.2-0.6%); partly because of stroke assessment between 48h and 30 days (37, 40), 
partly because the study cohort comprised patients with ACS, known to be at higher stroke 
risk (133). In RCTs no association between vascular access site and procedure-related stroke 
was reported but with respect to its the low incidence, they were not designed to answer that 
question either (37, 40). 
The main strength of our study is that data were comprehensively assessed and that the 
outcome variable was verified with a clear definition of procedure-related. Notwithstanding, 
our study has several limitations. Neurological complications may be under-reported to the 
SCAAR register. Additionally, data on co-morbidity were not obtained from NPR for 2011. 
Data on anticoagulation treatment were not included as SCAAR do not provide those for 
CA procedures. Additionally we cannot exclude that unknown confounders have biased the 
association of procedure-related stroke and access site. 
In summary, the radial access site may be associated with procedure-related stroke or TIA 
following CA and PCI.
Study IV 
The hypothesis of Study IV was that procedure-related cognitive impairment occurs after 
CA or PCI and that the number of cerebral microemboli and vascular access site are causally 
related to post-procedural cognitive impairment.
Of the 586 patients screened, 97 patients were included in the study. Ultimately, the results of 
93 patients were analysed including a subgroup of 35 patients with TCD recordings (Figure 
12). Eighty-six and 78 patients, respectively, performed the first and second follow-up MoCA 
test, and 77 patients completed all three MoCA tests (Figure 12). The vascular access site 
for all CA or PCI procedures was evenly distributed. The patients included were on average 
67 ± 8.7 years old, mainly men (20% women) with an average body mass index of 27.4 ± 
4.1 and normal renal function. Co-morbidities like hypertension and hyperlipidemia were 
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common (60% respectively), 20% had diabetes mellitus, previous MI or previous PCI, 
14% had previous stroke. Depression was prevalent in 14% of the patients and 57% had 
undergone more than 12 years of education. No stroke was observed during hospital stay, but 
one patient suffered a stroke two days after 
CA. The main reason for CA was chest pain 
and suspicion of angina pectoris. Normal 
findings on CA was found in 45% of all 
patients.
The median result of the baseline MoCA test 
was 27 (25-28) and did not change after the 
CA or PCI procedure (Figure 13). Subgroup 
analyses for women and PCI procedures 
showed similar MoCA test results.
Of those patients monitored with TCD during 
the catheterisation procedure, 33 patients 
completed the first follow-up MoCA test. 
MoCA test results were not correlated to the 
number of cerebral microemboli (Figure 14) 
or to access site.
Figure 12. Study design 
CA= coronary angiography, CABG= coronary artery bypass graft, MoCA= Montreal Cognitive Assessment, PCI= percu-
taneous coronary intervention, TCD= transcranial Doppler
Figure 13. Results of the Montreal Cogni-
tive Assessment (MoCA)
Boxplot with median, lower and upper quartile of MoCA 
test results at baseline (before the procedure), first 
and second follow-up (after the procedure) including 
whiskers from minimum to maximum MoCA test result.
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Of note, one third of all analysed patients (n=31) had <26 points on their baseline MoCA test, 
corresponding with MCI.
Discussion
In this study, no cognitive impairment following CA or PCI procedure was observed using the 
MoCA test. The results of the MoCA test were not correlated to the number of microemboli 
detected with TCD or to the access site from which the catheterisation procedure was 
performed. 
The body of evidence regarding cognitive function in CAD patients mainly comprises 
studies of CABG treatment, using a battery of different neuropsychological tests and 
various definitions of cognitive decline. Hence, a comparison with those studies is difficult. 
Studies with the focus on cognitive function in patients undergoing percutaneous cardiac 
procedures are rare. Selnes and co-workers did not find cognitive impairment in patients 
three months after CABG or PCI treatment, concluding that cognitive impairment is transient 
and reversible (134).  By using the MoCA test we did not detect cognitive decline within 3 or 
30 days of CA or PCI. The MoCA test is reported to detect mild cognitive impairment MCI 
with a sensitivity of 80% to100% and a specificity of 50% to76% (117).  Although the MoCA 
test has in comparison with mini-mental state examination (MMSE) a higher sensitivity and 
specifity, it is still a screening tool for MCI and subtle post-procedural changes may not be 
detected (135). Lund and co-workers have previously shown affected attention demanding 
tests following CA and PCI using a test battery of neuropsychological tests (27). In the 
subgroup monitored with TCD we also detected cerebral microemboli, but in disparity with 
the aforementioned study,  in a lower number, possibly due to the exclusion of patients with 
previous CABG, the avoidance of ventriculography and a low number of PCI procedures, all 
factors associated with a higher load of microembolisation (27).
No correlation between cognitive impairment and cerebral microemboli or vascular access 
site was present in our study. Lund and co-workers linked cerebral microemboli to new 
Figure 14. Correlation of cerebral microemboli and difference between baseline and first 
follow-up MoCA test results
Negative number indicates improvement in test results
Positive number indicates decline in test results
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cerebral lesions, detected on MRI, but interestingly post-procedural cognitive impairment was 
rather related to pre-catheterisation MRI injury and not the number of cerebral microemboli 
detected (27).  This implies that microembolisation may have various impacts in different 
individuals influenced by pre-existing cerebral lesions. 
Of note is that the occurrence of MCI before the catheterisation procedure was greater than 
expected (105, 136). Patients with MCI may have difficulties in decision making, following 
instructions and may have a higher risk for further cognitive decline based on an impaired 
cognitive reserve (137). The risk for conversion to dementia varies between 2-20% (105).
This study has several limitations. The inclusion rate was low, mainly depending on the 
patients´ preference for vascular access site, precluding randomisation. Furthermore, the 
limited number of patients with both completed MoCA tests and TCD recordings makes it 
difficult to draw any firm conclusions regarding the relationship between cognitive impairment 
and cerebral microemboli. Moreover, selection bias due to in-hospital follow-up MoCA tests 
and statistical type II error could have influenced our results. Using a test lacking sensitivity 
for detection of subtle changes in the brain function could also have contributed to the lack of 
detecting an association between cardiac catheterisation and cognitive impairment. Also, by 
including possibly healthier patients in our study, subtle changes may not be detectable due to 
a normal “brain reserve”. This highlights the importance of representative patient inclusion, 
which is not only influenced by exclusion criteria; it is also strongly influenced by the chosen 
study design. 
In summary, no cognitive decline in patients undergoing CA or PCI was detected. Thus, 
we found no significant correlation to cerebral microemboli or vascular access site. Mild 
cognitive impairment was highly prevalent in patients undergoing routine CA or PCI, 
underlining the importance of carefully performed procedures as those patients have a higher 
risk of further cognitive decline.
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GENERAL  DISCUSSION
For more than three decades CA and PCI have been performed for diagnosis and treatment 
of patients with CAD. Procedure-related complications are described to occur in 0.8-
5% of all procedures in large registries (60-62, 106) including 0.1-0.4% neurological 
complications (89, 91, 92). Despite pharmacological and technical advancements the rate of 
procedure-related stroke seems to be unchanged over time, possibly due to there now being 
interventions in higher risk groups previously excluded (138). By regression analysis, most 
recognised risk factors, including a few procedural factors, have been identified (89, 91, 93, 
94, 133). However, evidence of how to perform the procedure technically in order to reduce 
neurological complications is limited. The present thesis focuses therefore on the impact of 
different techniques for CA and PCI on procedure-related ischemic cerebral  complications.
Procedure-related stroke or TIA
Outcome
Procedure-related stroke is associated with a 5 to 10-fold increase in mortality compared 
with survival after PCI without stroke (127, 133, 139). Surviving a procedure-related stroke 
implies not only increased length of in-hospital stay (91, 133) but more than every other 
patient is left with residual neurological deficits, requiring skilled home-care in 26% (91). 
Despite the different impact of stroke and TIA for the affected patient, we have chosen to 
combine the entities in our analysis for several reasons. First, medical charts did not always 
include statements of a thorough neurological examination at 24h from the occurrence of 
symptoms, which made it impossible to conclude if symptoms were present or had been 
resolved at this time-point and thus if they were to be coded as ischemic stroke or TIA. 
Second, by combining stroke and TIA, the event rate increased enhancing statistical power. 
The impact of procedure-related TIA on mortality varies according to different studies. In 
PCI register studies Dukkipatti and co-workers and Genereux and co-workers did not find 
an association of procedure-related TIA with in-hospital (91) or 1-year mortality (140). In 
contrast, a recent study by Kwok and co-workers revealed that procedure-related TIA was 
independently associated with similar odds for death within 30 days compared to stroke 
(127). Likewise, a recently published study including over 2,800 patients hospitalised for 
“common” TIA or stroke reported that the 1-year all-cause mortality was similar among 
those with TIA compared to stroke (141). 
Definition of procedure-related stroke and contributing factors
From different register studies it is recognised that patients with ACS undergoing cardiac 
catheterisation have an increased risk of cerebrovascular events (91, 94, 127, 133, 142). The 
GRACE registry, evaluating outcome in ACS patients, showed an overall high in-hospital 
stroke rate (0.88%) and also a correlation to the severity of the ACS (with stroke incidence of 
1.3%, 0.9%, 0.5% for patients with STEMI, NSTEMI, UAP, respectively) (143). Only 35% 
of all strokes occurred during the first 6 days, with an increasing cumulative stroke incidence 
during in-hospital stay. Similarly, Guptill and co-workers found in patients with STEMI 
treated with primary PCI that only 27% of all strokes occurred within 24h whereas 43% of 
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all strokes occurred within 48h, with in median, 6 days to stroke manifestation (144). This 
implies that factors others than the procedure itself may be causal. Indeed, atrial fibrillation 
(AF) was, after congestive heart failure, the second most common in-hospital event in the 
GRACE study (143). AF occurs in 2-21% of all patients with NSTE-ACS (51) and in 28% 
of all STE-ACS patients (56) and is one of the most important predictors for stroke in the 
community setting (145). In most register studies procedure-related stroke is defined as 
occurring anytime after the catheterisation until discharge. Another limitation is that prevalent 
and incident AF is not considered (91, 92, 94, 127, 133). Underlining the importance of the 
time interval in which stroke occurs, Kawamura and co-workers showed in patients with 
non-STEMI and STEMI that risk factors for stroke differed with time, stroke within 24h 
from PCI was associated with PCI of a vein graft and less frequent use of glycoprotein 
IIb/IIIa inhibitors whereas stroke after 24h was associated with diabetes mellitus, anterior 
wall STEMI and  affected haemodynamics (142).  Anterior wall STEMI is associated with 
lower ejection fraction and higher risk for ventricular thrombus formation (146). Thus, for 
the distinction between patient- and procedure-related risk factors for stroke or TIA, a narrow 
time frame in relation to the procedure and the exclusion of present AF as potential embolic 
source is crucial, which is one of the main strengths in our study. 
We found a 30% higher risk for procedure-related stroke or TIA within 24h with the radial 
compared with the femoral access, when adjusting for known patient- and procedure-related 
risk factors. Also, most patient-related risk factors shown in other studies were confirmed in our 
study (91, 94, 128, 130). Contrary to the TOTAL trial, thrombectomy was not independently 
associated with procedure-related stroke in our study, a fact that may be explained by the low 
number of thrombectomies performed in patients with stroke or TIA in our study cohort (131). 
We included in our study CA and PCI procedures comprehensively, enhancing generalisability. 
Compared with PCI register studies, more patients with previous CABG, known to be at high-
risk of procedure-related stroke, were included in our study (42, 127, 133).
While subgroup analysis in RCTs showed a beneficial outcome of patients treated in high 
volume radial centres, in our study centre experience was not independently associated with 
procedure-related stroke or TIA (37, 40), possibly explained by various definitions of centre 
expertise and the absence of consensus regarding radial expertise. The radial access was 
increasingly used over time with 70% of radial procedures performed in 2011. In parallel, 
between 2009 and 2011, the risk for procedure-related stroke or TIA with the radial access 
was 40% higher compared with 2006-2008, although there was no statistically significant 
interaction between the time intervals. The reason for this is not clear. Factors associated 
with longer procedure time like access site crossover, and the number of procedures due to 
ACS, were stable compared with the earlier time periods. Noteworthy, patients with ACS 
had significantly higher radial access related stroke or TIA risk compared with procedures 
in stable patients. More severe vascular calcification, longer procedural times and enforced 
catheter advancement due to the urgent situation could be possible explanations. 
Previous studies have shown that debris from aortic plaques are dislodged from the vascular 
wall through catheter advancement and is suggested causal for procedure-related stroke (124, 
125). When using the radial access, plaque in the ascending aorta may be at higher risk 
of displacement, since the catheter bends sharply from the brachiocephalic trunk into the 
ascending aorta. Other embolic sources may be clots formed in and around the catheters, as 
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catheters and guidewires are highly prothrombotic, known to cause endothelial damage and 
reduced thromboresistance (126). Thus, procedural time, and number and size of the catheters 
used are factors shown to be independently associated with procedure-related stroke (91, 93). 
Accordingly, using the radial access with longer procedural times and higher crossover rates, 
compared with the femoral access, may constitute an additional embolic risk (19). 
In Study III, by analysing more than 300,000 CA and PCI procedures, the incidence of 
verified procedure-related stroke or TIA within 24h was 0.16% and the radial access was 
associated with a 30% higher risk. Although statistically not significant, with increased use of 
the radial access over time, the risk for procedure-related stroke or TIA increased. 
The radial access in different patient groups
Due to reduced access site bleedings, the radial access is nowadays preferred for patients with 
STE-ACS leading to mortality benefits (25). The MATRIX trial gave indications for similar 
benefits also for NSTE-ACS patients (40). Thus, the radial access is recommended over the 
femoral access, given the operator´s radialis expertise, in patients with ACS according to the 
ESC guidelines (51). However, the risk/benefit ratio in favour of the radial access may not be 
applicable to all patients. The adoption of the radial access in some subgroups is discussed below.
Women, underrepresented in clinical trials (37, 40), undergoing PCI are recognised to have 
a high risk of bleeding (147-149). In the SAFE-PCI trial women were randomised to either 
access site. This trial was stopped early due to the low event-rate, but did not show significant 
differences in bleeding or vascular access site complications following PCI between the 
access sites. On the contrary, a recently published register study addressing gender specific 
outcomes according to access site found a significant reduction in bleeding complications for 
both genders with greater benefit for women undergoing PCI (150). Approximately 40% of 
the PCIs included in this comprehensive analysis were elective PCIs. Here the radial, access 
was not associated with a decrease in 30 day mortality, whereas the opposite was shown for 
NSTE-ACS and STE-ACS in men and STE-ACS in women (150). Thus, male patients with 
stable angina may not benefit from the radial access. At the same time, as discussed above, 
ACS patients have been shown to have a higher risk of procedure-related stroke or TIA, 
possibly enhanced with the use of the radial access.
Another high-risk group for procedure-related stroke or TIA comprises patients with previous 
CABG. Michael and co-workers reported longer procedural times, greater contrast use and 
radiation exposure in patients with previous CABG undergoing CA and PCI with the radial 
compared with the femoral access (151). Also, as discussed above, longer procedural time 
is per se a risk factor for procedure-related stroke, further augmented with the radial access. 
Patients with cardiogenic shock (CS) have the worst prognosis and also more bleeding 
complications (71) among patients with ACS (152). A meta-analysis by Pancholy and co-
workers assessing outcome in patients with CS undergoing PCI showed reduced 30-day 
mortality and major adverse cardiac and cerebral event rate (see Table 1) with the radial 
access (36). Interestingly, bleeding rates, partly underreported, did not differ between the 
access sites, assuming that the sickest patients may not have been included in the analysis. In 
the absence of a palpable radial pulse due to haemodynamic instability, the femoral access is 
likely to be preferred, for the placement of haemodynamic support devices as well. 
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In summary, there is good evidence for a favourable risk/benefit ratio when using the radial 
access in patients with ACS. However, in special patient groups, such as procedures in stable 
CAD and for patients with previous CABG as well as for critically ill patients, it has not been 
shown that outcome benefits with the radial access outweigh the potential risk for procedure-
related stroke or TIA. Our findings should be the subject of future research given the further 
expanded use of the radial access.
Silent ischemic cerebral infarction and cognitive impairment
Contrary to the low incidence of procedure-related stroke and TIA following CA and PCI, 
the occurrence of clinically silent cerebral infarctions is considerably higher. According to 
a recently published meta-analysis, silent cerebral infarctions are found in 2-35% on MRI 
following cardiac catheterisation procedures (107). These parenchymal lesions have imaging 
characteristics of an infarct but the patient lacks clinical symptoms of  stroke or TIA (153). 
Silent cerebral infarcts have been shown to more than double the risk of subsequent stroke 
(100) and are also associated with cognitive decline, dementia and depression (154-157).
In the context of CABG
As a substantial proportion of patients develop cognitive decline after CABG (158), cerebral 
microemboli have been extensively studied with TCD, MRI and in postmortem studies, as 
they are thought to be implicated in the pathogenesis of cognitive impairment (159, 160). 
Autopsy studies following cardiopulmonary by-pass have shown microvascular lesions 
suggested to be caused by microembolic occlusions (161) and atherosclerotic emboli 
associated with severe atherosclerosis of the ascending aorta (162). The clinical impact of 
cerebral microemboli causal of cognitive impairment is yet undecided. Whereas five TCD 
studies in patients undergoing cardiac surgery showed an association between the number of 
microembolic signals and low post-operative performance, nine studies could not establish 
an association between microemboli and cognitive outcome, summarised by Kruis and co-
workers in a systematic review (163). This could be attributable to different TCD techniques 
used, as the earlier studies could not distinguish between gaseous and particulate microemboli, 
the latter suggested as being more harmful. In parallel, MRI studies in patients undergoing 
cardiac surgery have frequently shown new ischemic lesions reported in a meta-analysis 
(164). A recently published systematic review, aimed at exploring the association of post-
operative cognitive decline after cardiac surgery and new MRI lesions, included 20 studies 
with pre- and post-operative neuropsychological testing, whereof 6 showed an association 
between new MRI lesions and cognitive impairment whereas in 12 other MRI studies no 
association between ischemic lesions and cognitive decline was evident, in two studies no 
MRI changes have been observed (165). It should be noted that the authors refrained from 
performing a meta-analysis because of the studies´ heterogeneity (165).
In the context of vascular procedures
Also, other invasive cardiovascular procedures are associated with new ischemic lesions on 
MRI. It has been reported that new MRI lesions after endarterectomy and carotid angioplasty 
correlate with the number of intraoperative microembolic signals on TCD (99, 108). 
Cerebral microemboli and ischemic lesions on MRI are frequently observed after cardiac 
and cerebrovascular procedures and can potentially cause cognitive decline, yet a causal link 
needs to be confirmed.
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In the context of cardiac catheterisation 
We and others have used TCD to assess microembolisation in real-time during cardiac 
catheterisation to elucidate which procedural steps are associated with the occurrence of 
microemboli in the MCAs (27, 120-122). Thus, in Study I and Study II we showed that the 
vascular access site as a starting point for the catheterisation procedure and the technique 
used for catheter advancement when using the femoral access does have an impact on 
microembolisation. Our findings are limited by the absence of cerebral MRI. However, MRI 
studies have demonstrated a correlation between cerebral microemboli and silent cerebral 
infarctions (27, 99, 108). In contrast, Hamon and co-workers did not find an association 
between microemboli recorded with TCD and silent ischemic lesions on MRI following CA 
(96, 97, 119), possibly influenced by  the limited number of TCD recordings in a subset 
of included patients (97, 119). Also, the TCD techniques used were different between the 
studies: while Lund and co-workers used a traditional TCD technique (27), Hamon worked 
with power M-mode (PMD) (96, 97, 119). PMD is a more recently used TCD method which 
simultaneously displays the power and direction of blood flow signals over a range of depths, 
facilitating the “track” of microemboli but can potentially over-detect emboli (166, 167). Thus, 
cerebral microemboli, detected with TCD during different cardiovascular procedures are 
Figure 15. Overview of different sources by which silent cerebral infarcts can derive.
Adapted from Hassel, ME. Silent cerebral infarcts associated with cardiac disease and pro-
cedures (107). The arrow shows a small, hyper-intense lesion indicating cerebral infarction 
using dw-MRI.
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linked to silent cerebral infarcts on MRI. The association between microemboli and ischemic 
lesions is not yet explained in detail, as it is possibly influenced by multiple factors including 
the presence of aortic atheroma and the type of procedure performed. 
Mechanism of brain damage
To explore the mechanism by which cerebral microemboli may damage the brain, Wu and co-
workers showed in an animal model, that injection of microemboli in the carotid artery (cut 
whole blood clots) did not lead to cerebral infarcts but to neuronal apoptosis, via induction of 
inflammatory factors (168). This may indicate that the effect of cerebral microembolisation 
is more complex than anticipated with occlusion of cerebral microvessels. While gaseous 
microemboli are suggested as being more benign as they probably dissolve, they are linked to 
neurocognitive decline after CABG (169) and increased brain reactivity due to bioelectrical 
disturbances (170). The influence of pharmacological treatment on the occurrence of 
microemboli has been explored in patients with symptomatic carotid stenosis. Monotherapy 
with aspirin, showed in comparison with dual antiplatelet therapy, more microemboli detected 
with TCD (171). In parallel, Kim and co-workers showed in MRI studies that insufficient 
platelet inhibition and angiography of the internal mammary artery were associated with silent 
cerebral infarcts (172, 173). Using TCD, we found no correlation to anticoagulation treatment 
within Study I, II and IV. When comparing the count of microemboli, a similar number was 
detected regardless of monotherapy in Study I or dual antiplatelet therapy in Study II and IV, 
possibly explained by the overall low number of microemboli detected. 
Silent cerebral lesions and cognitive impairment
While it has been shown in population-based studies that silent cerebral lesion are associated 
with an increased stroke risk (174, 175), the risk for subsequent stroke following procedure-
related ischemic lesions has not been investigated. The theory of cumulative burden of 
multiple ischemic lesions contributing to cognitive decline is supported by TCD and MRI 
studies in patients with dementia (176, 177). However, an increased risk for stroke, cognitive 
decline, dementia and depression has yet not been observed following cardiac procedures in 
the absence of long-term follow up in these patients. We assessed cognitive function in Study 
IV in patients undergoing CA or PCI and did not find cognitive impairment when using the 
MoCA test. There was no correlation between cerebral microemboli detected with TCD and 
MoCA test results. Although the MoCA test discriminates cognitive impairment better than 
MMSE, the MoCA test is still a screening tool for dementia and might lack the sensitivity 
of the subtle cognitive assessment (135). Rodés-Cabau and co-workers studied patients with 
severe aortic stenosis undergoing TAVI and found no difference in cognitive function assessed 
with MMSE between patients with and without ischemic lesions with MRI (178).  In the 
study by Lund and co-workers, previously mentioned, cognitive impairment following CA or 
PCI was not correlated with the number of microemboli detected, but with pre-catheterisation 
MRI injury, supporting the theory on cumulative burden of ischemic lesions discussed 
above (27). However, two tests with the highest demand on learning and attention out of a 
neuropsychological test battery were associated with new lesions on MRI (27). This highlights 
that subtle changes in cognitive function after CA and PCI are difficult to detect.
In retrospect, when considering the results in Study IV, neuropsychological testing may have 
been more appropriate for the assessment of cognitive function. However, neuropsychological 
testing, widely used following CABG, differs substantially regarding methodology, criteria 
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for cognitive impairment, and choice of time-points for assessment (179). In addition, studies 
of assessment of cognitive function in patients undergoing PCI are rare. Selnes and co-
workers compared cognitive function in patients treated with CABG to those treated with 
PCI  without finding a difference at three months and one year (134). Interestingly, one 
third of the patients in Study IV had MoCA test results indicating MCI (118) which is a 
symptomatic pre-dementia stage on the continuum of cognitive decline (102). In support 
of this finding  Rosengart and co-workers reported an already high incidence of cognitive 
impairment in patients with CAD before treatment (137). The conversion of MCI to dementia 
varies between 2-20% per year (105). Thus, cardiac procedures aiming to increase quality-
of-life need to be critically reviewed according to the potential risk they may imply for 
impairment of cognitive function.  Even though the clinical impact of cerebral microemboli 
is yet undecided, their number should be kept as low as possible.
Future directions
The present thesis shows that different techniques used for CA and PCI have implications 
for the development of cerebral ischemic lesions, both overt and silent. To further elucidate 
the association between vascular access site and post-procedural cerebral injury, MRI studies 
could be an option. Given the low incidence, RCTs with the primary endpoint of procedure-
related stroke or TIA are difficult to implement. Thus, assessment of new ischemic cerebral 
lesions after CA of patients randomised to either access site could be a sufficient alternative. 
Preferably, patients with aortic stenosis, reported to have a high incidence of new ischemic 
lesions on MRI following CA, should be included. According to comparable data in this 
patient group (119), approximately 1,200 patients (600 in each group) are needed to detect a 
difference in the number of patients observed with new lesions on MRI after CA between the 
radial and femoral access site, with 80% power and a two-tailed significance level of 0.05.
Beyond vascular access site, various catheter and guidewire techniques should be assessed 
with the aim of individualising catheterisation techniques according to the patient´s risk profile 
and situation in which the procedure is performed. As TCD detects microemboli in real-time 
this technique can be used to understand the impact of different procedural stages during 
the catheterisation. MRI studies may be included to assess the procedure-related ischemic 
injury. Above all, future studies should include cognitive assessment. Cognitive function is 
insufficiently investigated in patients with CAD. There is need for a standardised reliable 
cognitive test with the ability to identify subtle cognitive changes feasible in the clinical 
context.  More research is required to further investigate the impact of cerebral microemboli 
caused by different cardiac procedures to enable long-term follow up relating to the risk of 
future stroke, dementia and depression.
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CONCLUSIONS
Specific conclusions
1. The number of cerebral microemboli was significantly higher when CA was per-
formed with the right radial access compared with the femoral access. Additionally, 
more cerebral microemboli were detected in the right middle cerebral artery with the 
right radial access whereas no difference occurred between the middle cerebral arter-
ies when the femoral access was used. This might entail a causal linkage as catheters, 
advanced through the right radial artery, bend sharply from the brachiocephalic trunk 
into the ascending aorta on their way to the coronary orifices.
2. The number of cerebral microemboli detected in the middle cerebral arteries was 
significantly higher when coronary catheters were advanced over a leading guidewire 
and subsequently flushed in the ascending compared with the descending aorta during 
CA with the femoral access. Guidewire technique has an impact on the occurrence 
of cerebral microemboli and might therefore influence the risk for silent ischemic 
cerebral lesions.
3. The radial access used for CA or PCI, may be associated with procedure-related 
stroke or TIA. Despite the low incidence of procedure-related stroke or TIA, these 
findings need to be confirmed in further studies, as the radial access will continue to 
be increasingly used.
4. No cognitive impairment was detected after CA and PCI using the Montreal Cogni-
tive Assessment. There was no significant correlation between results of the MoCA 
test and the number of cerebral microemboli or vascular access site.  Mild cognitive 
impairment was found frequently, entailing a higher risk for post-procedural cogni-
tive decline.
General conclusions
Even though procedure-related neurological complications are rare, the high volume of 
annually performed CAs and PCIs worldwide leads to a high number of affected patients 
underlining the importance of research in this field. We showed that the technique used for 
CA and PCI does have an influence on the occurrence of overt and silent ischemic cerebral 
complications. There are indications that the radial access is associated with procedure-related 
stroke or TIA. Throughout published studies have used varying definitions of procedure-related 
stroke, this makes comparison of study-results difficult and complicates the understanding 
of related risks. Previously, a wide range of definitions of bleeding complications in the 
context of ACS treatment were used. After the introduction of a consensus on standardised 
bleeding definition for cardiovascular trials (Bleeding Academic Research Consortium), the 
comparability between different studies significantly improved (180). In a similar manner, a 
standardised definition for procedure-related stroke or TIA would augment future research.
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In parallel, the association between cerebral microemboli, silent ischemic cerebral lesions 
and their clinical impact is yet unclear, probably due to the heterogeneity of the conducted 
studies. Refined and standardised cognitive assessment, preferably in a multicentre setting 
may resolve this question. 
Little research is published regarding different techniques for performing CA and PCI. If 
cerebral microemboli are harmful, it is important to find and use the best evidence-based 
technique. As investigation methods have developed, we have today better conditions for 
conducting clarifying studies. 
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